Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials*
2006
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
CYTOMEGALOVIRUS VIREMIA
1997
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
STAPHYLOCOCCUS AUREUS NASAL COLONIZATION AND ASSOCIATION WITH INFECTIONS IN LIVER TRANSPLANT RECIPIENTS
1998
The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: A systematic review and meta-analysis†
2004
Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant
2008
Fungal infections in the recipients of solid organ transplantation
2003
Antifungal Agents. Part II. The Azoles
1999
Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study
2005
Candida in Solid Organ Transplant Recipients
2009
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients
2006
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Systemic sclerosis
2017 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Outcomes of antifungal prophylaxis in high‐risk liver transplant recipients
2008
Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up
2000
Skeletal remodeling in health and disease
2007 Standout
Time to Detection of Cytomegalovirus (CMV) DNA in Blood Leukocytes Is a Predictor for the Development of CMV Disease in CMV-Seronegative Recipients of Allografts from CMV-Seropositive Donors following Liver Transplantation
1996
Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
2006
Update on antifungal treatment of invasive Candida and Aspergillus infections
2004
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Invasive Aspergillosis in Transplant Recipients
1999
Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients
1996
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
Bench-to-bedside review: Candida infections in the intensive care unit
2008
Portal hypertensive bleeding in cirrhosis
2016 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Pros and Cons: Usage of organs from donors infected with hepatitis C virus – Revision in the direct-acting antiviral era
2015
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study
2003
Treatment with Vitamin D and Calcium Reduces Bone Loss after Renal Transplantation
2002
Invasive Fungal Infections in Low-Risk Liver Transplant Recipients: A Multi-Center Prospective Observational Study
2006
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Hepatitis C Viral Infection in Liver Transplantation
1996
Effect of Ibandronate on Bone Loss and Renal Function after Kidney Transplantation
2001
Prevention of infections in solid organ transplant recipients
1999
the Role of Transjugular Intrahepatic Portosystemic Shunt (Tips) in the Management of Portal Hypertension: Update 2009
2009
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Defining the outcome of immunosuppression withdrawal after liver transplantation
1998
Fluconazole Prophylaxis against Fungal Colonization and Infection in Preterm Infants
2001
Prevention of Bone Loss in Renal Transplant Recipients
2003
Antifungal prophylaxis in liver transplant recipients
2009
Osteoporosis after solid organ and bone marrow transplantation
2003
Efficacy and safety of Amphotericin B Lipid Complex Injection (ABLC) in solid‐organ transplant recipients with invasive fungal infections
2000
Surgical Site Infections in Liver Recipients in the Early Posttransplantation Period: Etiological Agents and Susceptibility Profiles
2007
Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
2010
Bleeding Peptic Ulcer
1994 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Predicting bacteremia and bacteremic mortality in liver transplant recipients
2000
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Prophylaxis Strategies for Solid‐Organ Transplantation
2001
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Infection in Organ-Transplant Recipients
1998 Standout
Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination
1997
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation
1996
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding
1989
Efficacy of Pamidronate for Osteoporosis in Patients with Cystic Fibrosis following Lung Transplantation
2000
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Clinical application of regulatory T cells in type 1 diabetes
2013
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Zygomycetes in Human Disease
2000 Standout
Infections in solid-organ transplant recipients
1997
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Invasive Candidiasis
2015 Standout
A Comparison of Omeprazole and Placebo for Bleeding Peptic Ulcer
1997 Standout
Antifungal agents for preventing fungal infections in solid organ transplant recipients
2004
Genetic and epigenetic abnormalities in systemic sclerosis
2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Prophylactic Fluconazole in Liver Transplant Recipients
1999
De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on Survival
2004
Aspergillus fumigatusand Aspergillosis
1999 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Acute myopathy after liver transplantation
1998
Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients1
2002
Prosthetic Joint Infection
2014 Standout
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Risk of Malignant Neoplasms After Liver Transplantation: A Population-Based Study
2008
Hidden Killers: Human Fungal Infections
2012 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of E. Moreno being referenced
Neurologic complications in liver transplantation
2009
Randomized Trial of Fluconazole versus Nystatin for the Prophylaxis of Candida Infection following Liver Transplantation
1996
Relaparotomy After Pancreas Transplantation: Causes and Outcomes
2009
Treatment of mucor infection after liver or pancreas–kidney transplantation
2002
Clinical, Virological, and Histologic Evolution of Hepatitis C Virus Infection in Liver Transplant Recipients
1998
Calcitonin and bisphosphonates treatment in bone loss after liver transplantation
1995
Association of HLA Class II Genes with Systemic Sclerosis in Spanish Patients
2009
Liver Transplantation from Anti-Hepatitis C Virus-Positive Donors: Our Experience
2012
Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients
1994
Liver transplantation and transjugular intrahepatic portosystemic shunt
2003
De novo tumors after orthotopic liver transplantation
2002
Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies
1993
Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer.
1999
Somatostatin in the treatment of severe upper gastrointestinal bleeding: A multicentre controlled trial
1986
Major bacterial infections following liver transplantation: a prospective study.
1992
High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in liver transplant recipients.
1995
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients
1992
Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
2002